EC 0652

Drug Profile

EC 0652

Alternative Names: 99mTc-EC-0652; DUPA-99mTc; EC 1169 companion diagnostic - Endocyte; EC0652

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Endocyte
  • Class Imaging agents; Radiopharmaceutical diagnostics
  • Mechanism of Action Radionuclide imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Prostate cancer

Most Recent Events

  • 28 Jan 2015 Phase-I clinical trials in Prostate cancer (Diagnosis) in USA (unspecified route) prior to January 2015
  • 24 Aug 2012 Phase-0 clinical trials in Prostate cancer diagnosis in USA (unspecified route)
  • 24 Feb 2011 Preclinical trials in Prostate cancer diagnosis in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top